Event Actions powered by Trumba

Updates in Oncology 2024 Philadelphia: with Proceedings from International Medical Meetings

When

Wednesday, June 12, 2024, 5 – 9:15pm EDT

Location

In Person at The Hilton Philadelphia OR
Virtually

Type of Event

CME Course, Conference

Sponsor

Abramson Cancer Center

Who Should Attend

This activity has been designed for medical, surgical and radiation oncologists, hematologists/oncologists, hematology/oncology fellows, radiologists, neurological surgeons, thoracic surgeons, urologists, gastroenterologists, pulmonologists, dermatologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

Upon completion of this conference, participants should be able to:

Identify recent advances in immunotherapy for cancer treatment
Implement new clinical findings to a broad range of tumor types
Identify issues related to extent of therapy by genomics, stage, and patient condition

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

PHYSICIANS: Penn Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: This program awards 3.25 NCPD hours.

PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 3.25 Category 1 credits for completing this activity.

Disclosures

Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.

Details

ATTENTION:
Name badges will be required. we strongly recommend that all in person attendees complete their registration by Friday, June 7,2024. Thank you for your cooperation!

Sorry. The sign-up deadline for this event has passed